Published in Proteomics Weekly, March 3rd, 2003
"This RARE accounted for one half of the RA responsiveness of CD18. However, unexpectedly, one half of the dynamic response to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2003-03-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.